4,000 healthcare workers to get Covid vaccine on first day in Telangana daijiworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daijiworld.com Daily Mail and Mail on Sunday newspapers.
No choice between vaccines for recipients
Updated:
Updated:
Distribution dependent on location of vaccination centre, operations internal to Health dept: officials
Share Article
AAA
Health staff supervising arrangements at Chest Hospital of Erragadda, in Hyderabad, which will serve as a COVID-19 vaccination centre on Saturday. | Photo Credit:
RAMAKRISHNA G.
Distribution dependent on location of vaccination centre, operations internal to Health dept: officials
The recipients of COVID-19 vaccine will not have a say with regard to the two choices Covishield and Covaxin but they will have to sign a consent form if they are administered the latter.
This was informed by Director of Medical Education K. Ramesh Reddy and Director of Public Health G. Srinivasa Rao at a press conference in the city on Friday. They said distribution of brands to vaccination centres was dependent on their geographical location and operations internal to Health department. So, the recipients wi
Hyderabad: Unidentified man found hanging from a tree at NIMS
By Nikita Venkatesh| Published: 11th January 2021 2:57 pm IST Representational Image
Hyderabad: An unidentified man in his mid-forties was found hanging from a tree on the premises of the Nizam’s Institute of Medical Sciences, Panjagutta on Monday morning.
The man was found hanging from the tree behind the Millennium Block on the hospital premises and the police suspect that he had died by suicide.
Upon finding him, the hospital authorities immediately informed the Punjagutta police who reached the spot and immediately sent the body for autopsy.
The investigation is still underway and further details are awaited.
Bharat Biotech concludes recruitment for Covaxin s phase 3 study
By
Ashish Srivastava ( IANS) |
Published on
Thu, Jan 7 2021 12:51 IST |
0 Views
Covaxin generated excellent safety data, says Bharat Biotech. Image Source: IANS News
New Delhi, Jan 7 : Hyderabad-based vaccine manufacturer Bharat Biotech has concluded the recruitment of volunteers for the phase III trials of its Covid vaccine, Covaxin, on Thursday after achieving the sample size it had promised to the ethics committee. The firm has achieved the targeted number of volunteers, which is 25,800 participants, in total.
The recruitment was supposed to be concluded by December 31 but was extended by a week since it was short of 4,000 volunteers that time.
Covaxin trial: Bharat Biotech completes recruitment for phase III study
IANSJan 7, 2021, 13:05 IST
BUSINESSINSIDER
Bharat Biotech has concluded the recruitment of
volunteers for the phase III trials of its Covid vaccine,
Covaxin, on Thursday after achieving the sample size it had promised to the ethics committee. The firm has achieved the targeted number of volunteers, which is 25,800 participants, in total.
The recruitment was supposed to be concluded by December 31 but was extended by a week since it was short of 4,000 volunteers that time. Dr. Sanjay Kumar Rai, head of community medicine and principal investigator of the trial at All
India Institute of All